Jie Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jie Yang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Xinrong Guo
The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523808, China; School of Public Health, Guangdong Medical University, Dongguan, 523808, China
2 shared publications - Yubo Wei
School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, 650500, China
2 shared publications - Derong Cao
South China University of Technology
1 shared publication - Huiqun Huang
Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan 523808, China
1 shared publication Jiahan Xu
School of Pharmacy, School of Public Health, Guangdong Medical University, Dongguan, 523808, China
1 shared publication- Jiang Pi
The First Dongguan Affiliated Hospital Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics School of Medical Technology Guangdong Medical University Dongguan China
1 shared publication
Latest Publications
- 23 January 2024
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 16 (6) , 930-938
A graphitic C 3 N 4 nanocomposite-based fluorescence platform for label-free analysis of trace mercury ions
The fluorescence sensor used graphitic carbon nitride nanosheets loaded with graphitic carbon nitride quantum dots (CNQDs/CNNNs) nanocomposite to analyze Hg 2+ using a quenching mechanism studied by DFT.
- 23 January 2024
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 16 (6) , 930-938
A graphitic C 3 N 4 nanocomposite-based fluorescence platform for label-free analysis of trace mercury ions
The fluorescence sensor used graphitic carbon nitride nanosheets loaded with graphitic carbon nitride quantum dots (CNQDs/CNNNs) nanocomposite to analyze Hg 2+ using a quenching mechanism studied by DFT.
- Top Cited PapersOpen Access
- 2 July 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (7) , 1868
Gold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy
Cancer immunotherapy is an innovative treatment strategy to enhance the ability of the immune system to recognize and eliminate cancer cells. However, dose limitations, low response rates, and adverse immune events pose significant challenges. To address these limitations, gold nanoparticles (AuNPs) have been explored as immunotherapeutic drug carriers owing to their stability, surface versatility, and excellent optical properties. This review provides an overview of the advanced synthesis routes for AuNPs and their utilization as drug carriers to improve precision therapies. The review also emphasises various aspects of AuNP-based immunotherapy, including drug loading, targeting strategies, and drug release mechanisms. The application of AuNPs combined with cancer immunotherapy and their therapeutic efficacy are briefly discussed. Overall, we aimed to provide a recent understanding of the advances, challenges, and prospects of AuNPs for anticancer applications.
- 2 July 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (7) , 1868
Top Cited PapersOpen AccessGold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy
Cancer immunotherapy is an innovative treatment strategy to enhance the ability of the immune system to recognize and eliminate cancer cells. However, dose limitations, low response rates, and adverse immune events pose significant challenges. To address these limitations, gold nanoparticles (AuNPs) have been explored as immunotherapeutic drug carriers owing to their stability, surface versatility, and excellent optical properties. This review provides an overview of the advanced synthesis routes for AuNPs and their utilization as drug carriers to improve precision therapies. The review also emphasises various aspects of AuNP-based immunotherapy, including drug loading, targeting strategies, and drug release mechanisms. The application of AuNPs combined with cancer immunotherapy and their therapeutic efficacy are briefly discussed. Overall, we aimed to provide a recent understanding of the advances, challenges, and prospects of AuNPs for anticancer applications.